Ke He

11PUBLICATIONS
17CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Cancer cell biologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
Tri- and Difluoromethylated Spiro[5.5]trienones Inhibit the Growth of Cancer Cells In Vitro and In Vivo.

|Apr 15, 2026
SLC1A5 prevents aortic aneurysm and dissection by glutaminolytic-epigenetic orchestration of vascular smooth muscle cell homeostasis.

|Jan 28, 2026
An Integrative Roadmap for Advancing Colorectal Cancer Organoid.

Youqing Zhu, Ke He, Zhi Shi

|Dec 30, 2025
H89 Reverses Multidrug Resistance in Colorectal Cancer by Inhibiting the ATPase Activity of ABCB1.

Wei-Jing Liu, Yi-Yao Shan, Huan Wang

|Nov 27, 2025
Targeting the ZMYM2-ANXA9 Axis: Organoid Models Illuminate a Novel Pathway to Overcome Oxaliplatin Resistance in Colorectal Cancer.

Shi-Jie Zeng, Ke He, Zhi Shi

|Jul 05, 2024
Phase separation of RNF214 promotes the progression of hepatocellular carcinoma.

Zheng-Jie He, Ke He, Song-Wang Cai

Pageof 2

Frequent Collaborators

6 joint publications

Zhi Shi

3 joint publications

Guoan Xiang

1 joint publications

Lu Wu

1 joint publications

Qianshan Ding